The European Commission has granted the first licence to market a vaccine in preparation for a pandemic of H5N1 bird flu in Europe, British pharmaceutical firm GlaxoSmithKline has said.(AFP/File/Ho)AFP - The European Commission has granted the first licence to market a vaccine in preparation for a pandemic of H5N1 bird flu in Europe, British pharmaceutical firm GlaxoSmithKline said on Monday.


Read the full story